LNAI Return on Tangible Equity | Lunai Bioworks Inc.

Lunai Bioworks Inc. (LNAI) Return on Tangible Equity

2026-03-31: Return Tang Equity 820.46%.
2025-12-31: Return Tang Equity 638.67%.
2025-09-30: Return Tang Equity 683.71%.
2025-06-30: Return Tang Equity 647.80%.

Complete source-backed return tang equity history.

Available history: 2011-12-31 to 2026-03-31
Data captured: 2026-09-04

Historical Return Tang Equity

Date	Return Tang Equity
2026-03-31	820.46%
2025-12-31	638.67%
2025-09-30	683.71%
2025-06-30	647.80%
2025-03-31	276.07%
2024-12-31	486.12%
2024-09-30	613.84%
2024-06-30	322.92%
2024-03-31	-2190.50%
2023-12-31	-129.16%
2023-09-30	-117.37%
2023-06-30	-113.96%
2023-03-31	-196.01%
2022-12-31	-196.67%
2022-09-30	-188.80%
2022-06-30	-186.16%
2022-03-31	-27.12%
2021-12-31	-24.94%
2021-09-30	-22.37%
2021-06-30	-16.40%
2021-03-31	-8.94%
2020-12-31	-7.28%
2020-09-30	-6.38%
2020-06-30	-7.39%
2020-03-31	-3.88%
2019-12-31	-4.61%
2019-09-30	-13.56%
2019-06-30	-11.16%
2019-03-31	-15.07%
2018-12-31	-14.94%
2018-09-30	189.53%
2018-06-30	-4.29%
2018-03-31	1.64%
2017-12-31	-100.19%
2017-09-30	-59.78%
2017-06-30	-152.15%
2017-03-31	157.20%
2016-12-31	190.25%
2016-09-30	234.08%
2016-06-30	224.44%
2016-03-31	1083.20%
2015-12-31	-988.38%
2015-09-30	-555.39%
2015-03-31	-127.91%
2014-12-31	-72.33%
2014-09-30	95.47%
2014-06-30	80.66%
2014-03-31	84.23%
2013-12-31	112.09%
2013-09-30	362.42%
2013-06-30	258.61%
2013-03-31	146.76%
2012-12-31	0.70%
2012-09-30	106.56%
2012-06-30	165.78%
2012-03-31	218.90%
2011-12-31	369.72%

Annual Return Tang Equity

Date	Return Tang Equity
2025-06-30	647.80%
2024-06-30	322.92%
2023-06-30	-113.96%
2022-06-30	-186.16%
2021-06-30	-16.40%
2020-06-30	-7.39%
2019-06-30	-11.16%
2018-06-30	-4.29%
2017-06-30	-152.15%
2016-06-30	224.44%
2014-12-31	-71.94%
2013-12-31	112.09%
2013-03-31	73.32%
2012-03-31	218.90%

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
PMV Pharmaceuticals, Inc. (PMVP)	United States	$0.071B	-0.95
TENAX THERAPEUTICS, INC. (TENX)	United States	$0.071B	-7.17
PLIANT THERAPEUTICS, INC. (PLRX)	United States	$0.071B	-0.76
Spero Therapeutics, Inc. (SPRO)	United States	$0.073B	17.41
Cingulate Inc. (CING)	United States	$0.073B	-2.64
Yarrow Bioscience, Inc. (YARW)	United States	$0.070B
Aldeyra Therapeutics, Inc. (ALDX)	United States	$0.074B	-5.57
Connect Biopharma Holdings Ltd (CNTB)		$0.069B	-2.17
OS Therapies Inc (OSTX)	United States	$0.076B	-2.17
Verrica Pharmaceuticals Inc. (VRCA)	United States	$0.076B	-3.39